Ford says it will reduce costs to boost China business

 Ford said on Monday it was working to reduce costs in China as it strives to recover from a long sales slump in the world’s largest auto market.

“Our costs are not competitive, and we are working internally and with our partners to reduce costs in all areas,” a representative of Ford China told Reuters in a statement.

“We can only win through a lean and agile organisation. These actions are necessary for us to build a healthier and more sustainable business in China,” the company added.

Local Chinese media reported last week, citing unnamed sources, that the company planned to cut 1,300 jobs in China.

The company did not comment on how it would cut costs. Reuters was not able to independently verify the reported job cuts.

Ford’s sales in China have been sliding since 2016 but its exports from the country nearly doubled in 2022, industry data showed.

Ford will also restructure its China operations to turn one of its joint ventures into an export hub for low-cost commercial electric and combustion vehicles, chief executive Jim Farley said in April.

Source : Reuters

GLOBAL BUSINESS AND FINANCE MAGAZINE

Recent Posts

IMF strategy chief urges countries to maintain price stability

Christian Mumssen, the fund's new director of ​strategy, cited a rapid succession of major shocks…

3 days ago

Gold bounces from two-week low, markets await US inflation data

Gold bounces from two-week low, markets await US inflation data. Gold ticked higher on Tuesday…

3 days ago

Dollar dips ahead of US inflation data, supported by rate outlook

Reuters poll forecasts U.S. headline inflation at 3.8%.  The dollar remained in sight of 13-month…

3 days ago

After Credit Suisse, markets find bail-in less credible

When Credit Suisse failed in March 2023, Swiss authorities, against market expectations, set aside the…

3 days ago

Higher utilisation explains the recent surge in productivity growth

US labour productivity has accelerated since 2022. Output per hour grew around 2.5% per year…

3 days ago

Harmonising access and reinventing the procurement of innovative medicines in Europe

Europe pays for innovative medicines through 27 uncoordinated national negotiations, generating access delays, cross-country pricing…

4 days ago